Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab

Abstract

Rituximab reduces humoral responses following influenza vaccination in RA patients, with a modestly restored response 6-10 months after rituximab administration. Previous influenza vaccination in rituximab-treated patients increases pre- and postvaccination titers. RA activity was not influenced.